| Fenoprofen and ketoprofen amides as potential antitumor agents M Marjanović, B Zorc, L Pejnović, M Zovko, M Kralj Chemical Biology & Drug Design 69 (3), 222-226, 2007 | 49 | 2007 |
| Rat brain glucose transporter-2, insulin receptor and glial expression are acute targets of intracerebroventricular streptozotocin: risk factors for sporadic Alzheimer’s disease? A Knezovic, A Loncar, J Homolak, U Smailovic, J Osmanovic Barilar, ... Journal of neural transmission 124, 695-708, 2017 | 47 | 2017 |
| Genetic polymorphisms of cytochrome P450 enzymes: CYP2C9, CYP2C19, CYP2D6, CYP3A4, and CYP3A5 in the Croatian population L Ganoci, T Božina, N Mirošević Skvrce, M Lovrić, P Mas, N Božina Drug metabolism and personalized therapy 32 (1), 11-21, 2017 | 42 | 2017 |
| CYP2C9 and ABCG2 polymorphisms as risk factors for developing adverse drug reactions in renal transplant patients taking fluvastatin: a case–control study N Miroševic Skvrce, N Božina, L Zibar, I Barišic, L Pejnovic, ... Pharmacogenomics 14 (12), 1419-1431, 2013 | 40 | 2013 |
| ABCG2 gene polymorphisms as risk factors for atorvastatin adverse reactions: a case–control study N Mirošević Skvrce, V Macolić Šarinić, I Šimić, L Ganoci, ... Pharmacogenomics 16 (8), 803-815, 2015 | 39 | 2015 |
| Interaction between ABCG2 421C>A polymorphism and valproate in their effects on steady‐state disposition of lamotrigine in adults with epilepsy I Klarica Domjanović, M Lovrić, V Trkulja, Ž Petelin‐Gadže, L Ganoci, ... British journal of clinical pharmacology 84 (9), 2106-2119, 2018 | 28 | 2018 |
| Brain-derived neurotrophic factor serum and plasma levels in the treatment of acute schizophrenia with olanzapine or risperidone: 6-week prospective study S Kudlek Mikulic, A Mihaljevic-Peles, M Sagud, M Bajs Janovic, L Ganoci, ... Nordic journal of psychiatry 71 (7), 513-520, 2017 | 24 | 2017 |
| Association of CNR1 genotypes with changes in neurocognitive performance after eighteen-month treatment in patients with first-episode psychosis MR Kuzman, DB Kuharic, L Ganoci, P Makaric, I Kekin, LR Gajsak, ... European psychiatry 61, 88-96, 2019 | 19 | 2019 |
| ABCB1, ABCG2 and CYP2D6 polymorphism effects on disposition and response to long-acting risperidone L Ganoci, V Trkulja, M Živković, T Božina, M Šagud, M Lovrić, N Božina Progress in Neuro-Psychopharmacology and Biological Psychiatry 104, 110042, 2021 | 15 | 2021 |
| Drug-drug-gene interactions as mediators of adverse drug reactions to diclofenac and statins: a case report and literature review N Božina, L Ganoci, L Simičević, K Gvozdanović, I Klarica Domjanović, ... Arhiv za higijenu rada i toksikologiju 72 (2), 128-128, 2021 | 13 | 2021 |
| CYP2C19* 2 genotype influence in acute coronary syndrome patients undergoing serial clopidogrel dose tailoring based on platelet function testing: Analysis from randomized … J Samardzic, N Bozina, B Skoric, L Ganoci, M Petricevic, M Krpan, ... International Journal of Cardiology 186, 282-285, 2015 | 12 | 2015 |
| CYP2D6 *6/*6 genotype and drug interactions as cause of haloperidol-induced extrapyramidal symptoms I Šimić, I Potočnjak, I Kraljičković, M Stanić Benić, I Čegec, D Juričić Nahal, ... Pharmacogenomics 17 (13), 1385-1389, 2016 | 10 | 2016 |
| DPYD polymorphisms c.496A>G, c.2194G>A and c.85T>C and risk of severe adverse drug reactions in patients treated with fluoropyrimidine‐based protocols N Božina, I Bilić, L Ganoci, L Šimičević, S Pleština, L Lešnjaković, ... British journal of clinical pharmacology 88 (5), 2190-2202, 2022 | 9 | 2022 |
| Use of pharmacogenomics in elderly patients treated for cardiovascular diseases N Božina, M Vrkić Kirhmajer, L Šimičević, L Ganoci, N Mirošević Skvrce, ... Croatian medical journal 61 (3), 147-158, 2020 | 9 | 2020 |
| Integration of complementary biomarkers in patients with first episode psychosis: research protocol of a prospective follow up study M Rojnic Kuzman, P Makaric, D Bosnjak Kuharic, I Kekin, ... Psychiatria Danubina 31 (2), 162-171, 2019 | 9 | 2019 |
| The role of Cyp2d6, Cyp3a4/5, and Abcb1 polymorphisms in patients using long-acting injectable risperidone L Ganoci, M Lovrić, M Živković, M Šagud, IK Domjanović, N Božina Clinical therapeutics 38 (10), e10-e11, 2016 | 9 | 2016 |
| Loss of function polymorphisms in SLCO1B1 (c.521T>C, rs4149056) and ABCG2 (c.421C>A, rs2231142) genes are associated with adverse events of … I Merćep, I Radman, V Trkulja, T Božina, L Šimičević, E Budimir, L Ganoci, ... European journal of clinical pharmacology, 1-10, 2022 | 8 | 2022 |
| Association of HSPA1B genotypes with psychopathology and neurocognition in patients with the first episode of psychosis: a longitudinal 18-month follow-up study D Bosnjak Kuharic, N Bozina, L Ganoci, P Makaric, I Kekin, N Prpic, ... The Pharmacogenomics Journal 20 (5), 638-646, 2020 | 8 | 2020 |
| Remission is not associated with DRD2 rs1800497 and DAT1 rs28363170 genetic variants in male schizophrenic patients after 6-months monotherapy with olanzapine M Zivkovic, A Mihaljevic-Peles, D Muck-Seler, M Sagud, L Ganoci, ... Psychiatria Danubina 32 (1), 84-91, 2020 | 6 | 2020 |
| Dapsone‐induced agranulocytosis—possible involvement of low‐activity N‐acetyltransferase 2 I Potočnjak, R Likić, I Šimić, D Juričić Nahal, I Čegec, L Ganoci, N Božina Fundamental & clinical pharmacology 31 (5), 580-586, 2017 | 6 | 2017 |
